• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: February 20-24, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

February 20-24, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs2/23/12Orlando, FLN/AN/ASpeech at GPhA’s Annual Meeting
John M. Taylor, III, J.D., Counselor to the Commissioner2/23/12Silver Spring, MDDeb Autor, Steve Solomon, Carolyn Becker, Sharon Mayl, Kristin Mcnamara, Jennifer Devine, Charlotte ChristinElizabeth Wroe, Hank Lambert, Gary Coleman, Abel Torres, Laura Snell (Consumer Protection and Standards Company Underwriters Labs)Food Issues
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy2/20/12-2/24/12 N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs2/20/12-2/24/12 N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs2/20/12 - 2/24/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products2/20/12-2/24/12N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Acting Chief Counsel2/20/12-2/24/12N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning2/20/12-2/24/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine2/24/12Rockville, MDTracey Forfa, Steve Vaughn, Merton Smith, Steve Yan, John BakerShian-Jyue Du (Taipei Economic and Cultural Representative Office in the United States)Drug Approval Process
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health2/23/12Washington, DCN/AVarious participants from private industry, Government and academiaHealth and Environmental Sciences Institute Emerging Issues
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition2/20/12 - 2/24/12N/AN/AN/ANo Significant Meetings
Jim Sigg, Acting Associate Commissioner for Operations2/20/12-2/24/12N/AN/AN/ANo Significant Meeting
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research2/20/12-2/24/12N/AN/AN/ANo Significant Meetings  
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/24/12Silver Spring, MDChristy Foreman,Thomas Gross, Susan Cummins, William Maisel, Gregory CampbellMike Minogue, David Weber, Karim Benali, Carol Pekar (Abiomed)Medical Devices 
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research2/24/12Little Rock, ARN/AN/AFDA/NCTR and State of Arkansas Memorandum of Understanding
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco2/22/12San Francisco, CAN/AN/AMolecular Med Tri-Con 2012: Inaugural Genomic Screening and Diagnosis of Human Diseases Program
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods2/24/12Washington, DCCaitlin Boon, Don KraemerCarolyn Brickey, Sandra Eskin (Pew Charitable Trusts)Produce
Mary Lou Valdez, Associate Commissioner for International Programs2/20/12-2/24/12N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs2/20/12-2/24/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research2/20/12-2/24/12N/AN/AN/ANo Significant Meetings